Introduction
============

Imidazo\[1,2-*a*\]pyridines have been reported to display a wide range of biological activities \[[@R1]--[@R5]\], and these skeletons are found in various clinical drugs such as zolpidem (**I**), alpidem (**II**), and olprinone (**III**), which were approved for the treatment of insomnia, anxiety and acute heart failure, respectively ([Fig. 1](#F1){ref-type="fig"}) \[[@R6]\]. Furthermore, the isoquinoline motif represents a privileged medicinal skeleton widely found in a number of natural alkaloids and pharmaceutically active compounds \[[@R7]\]. Some of them exhibit diversified biological properties, including anti-inflammatory \[[@R8]\], antibacterial \[[@R9]\], antiviral \[[@R10]\], and antitumor activities \[[@R11]\]. For example, the natural alkaloids berberine (**IV)** and narciclasine (**V**) possess antiplasmodial and antiviral activity, respectively \[[@R12]--[@R13]\]. Indotecan (**VI**) and its analog idimitecan (**VII**) were identified as topoisomerase I inhibitors, and were promoted into phase I clinical trials \[[@R14]\].

![Representative bioactive imidazo\[1,2-*a*\]pyridine and isoquinoline-containing derivatives.](Beilstein_J_Org_Chem-13-817-g002){#F1}

Multicomponent reactions (MCRs) \[[@R15]--[@R19]\], comprising three or more components, provide straightforward approaches to a wide range of heterocycles through the formation of various bonds in a one-pot process. These reactions not only greatly accelerate chemical syntheses \[[@R20]\], but also allow access to diverse chemical structures \[[@R21]\] from readily accessible building blocks. In the past decades, considerable efforts have been made towards the development of new MCRs and their application to the diversity-oriented synthesis of biologically relevant molecules for drug discovery \[[@R22]--[@R27]\].

The Ugi reaction \[[@R28]\], an elegant pioneer of a multicomponent reaction, represents a powerful synthetic tool to assemble versatile peptide-like compounds. It has found many applications in the facile synthesis of natural products and biologically interesting molecules \[[@R29]--[@R30]\]. Although the Ugi-4CR generates linear α-acylamino-amides, a wide range of heterocycles are accessible through the combination with other transformations (post-transformation strategy) \[[@R31]\]. For example, the Ugi/Diels--Alder process leads to the formation of benzofurans and indoles \[[@R32]\] as well as to structurally complex polycyclic ring systems \[[@R33]\]; an Ugi/aza-Wittig process allowed for the synthesis of 2,5-disubstituted 1,3,4-oxadiazoles \[[@R34]\]; the Ugi/Pictet--Spengler sequence provided a rapid and efficient approach to polycyclic natural product-like alkaloids \[[@R35]\]. Accordingly, the combination of the Ugi reaction with other transformations proved to be powerful strategies for the efficient synthesis of novel heterocycles. In 1998, the Groebke--Blackburn--Bienaymé (GBB) reaction, an Ugi-3CR variant was discovered by three groups independently \[[@R36]--[@R38]\]. The GBB reaction of an amidine, an aldehyde and an isocyanide proceeds through the isocyanide-involving formal \[4 + 1\] cycloaddition \[[@R39]\] affording the biologically important imidazo\[1,2-*a*\]pyridine scaffold. Due to the atom and step economy, high efficiency and intriguing biological profiles of the products, the GBB reaction has attracted broad attention in the field of organic synthesis \[[@R40]--[@R42]\]. In order to expand the structural diversity of GBB products, further investigation of GBB-based synthetic strategies remains highly desirable.

In continuation of our research on the development of MCR strategies for the rapid library synthesis of biologically interesting heterocycles \[[@R43]--[@R47]\], we were interested in a practical synthetic strategy towards imidazo\[1,2-*a*\]pyridine-fused isoquinoline systems. We believe that this type of polycyclic systems may have interesting biological profiles \[[@R48]\]. Herein, we report our recent efforts on the development of a post-GBB transformation strategy for the concise synthesis of diverse imidazo\[1,2-*a*\]pyridine-fused isoquinoline systems.

Results and Discussion
======================

From a design perspective, we envisioned that the imidazo\[1,2-*a*\]pyridine-fused isoquinoline **6a** \[[@R49]--[@R50]\] could be constructed through a GBB reaction/cyclization strategy ([Scheme 1](#C1){ref-type="fig"}). The intermediate GBB product **4a** could be constructed starting from 2-ethynylbenzaldehyde (**2a**) through an imine formation/formal \[4 + 1\] cycloaddition/\[1,3\]-H shift. The so obtained GBB product imidazo\[1,2-*a*\]pyridine **4a** bearing an amino group and an acetylene unit may then undergo a sequential 6-*exo*-dig cyclization/retro-ene reaction to form the desired imidazo\[1,2-*a*\]pyridine-fused isoquinoline **6a**. The cyclization reaction could be realized with the aid of silver or gold catalysts \[[@R51]--[@R52]\].

![GBB-based MCR strategy for the imidazo\[1,2-*a*\]pyridine-fused isoquinoline derivatives.](Beilstein_J_Org_Chem-13-817-g003){#C1}

With this idea in mind, we commenced our studies by investigating the GBB reaction of 2-aminopyridine (**1a**), 2-ethynylbenzaldehyde (**2a**) and *tert*-butylisocyanide (**3**). The GBB reaction proceeded smoothly in MeOH in the presence of catalytic PTSA or HClO~4~ at room temperature to afford imidazo\[1,2-*a*\]pyridine **4a** in 90% yield, and the cyclized product **6a** was not detected under these mild conditions. Subsequent heating of **4a** in refluxing 1,4-dioxane or toluene failed to deliver the expected product **6a**, even under acidic or basic conditions.

Then, we turned to Ag and Au catalysts and investigated the metal-catalyzed intramolecular cyclization reaction of **4a** and the results are collected in [Table 1](#T1){ref-type="table"}. First, we investigated AgOTf as the catalyst, which afforded the cyclized product **6a** in 12% yield in refluxing CH~2~Cl~2~ in the presence of 10 mol % of catalyst. The yield was increased to 45% when replacing CH~2~Cl~2~ with CHCl~3~, whereas only a trace amount of the desired product was obtained in refluxing CH~3~CN or 1,4-dioxane ([Table 1](#T1){ref-type="table"}, entries 1--4). It revealed that the solvent plays a key role in this cyclization reaction. For comparison, we tested also AgSbF~6~ as the catalyst and it was found to be less effective than AgOTf ([Table 1](#T1){ref-type="table"}, entry 5). To improve the reaction efficiency, we next evaluated the cyclization reaction in refluxing CHCl~3~ in the presence of a range of Au catalysts. Although almost no reaction took place with Au(PPh~3~)Cl as the catalyst, the use of Au(PPh~3~)NTf~2~ resulted in a satisfactory yield (70%) of the product ([Table 1](#T1){ref-type="table"}, entries 6--9). Motivated by this result, other Au catalysts were further surveyed, and Au(JohnPhos)Cl was found to be the most efficient, delivering **6a** in 78% yield ([Table 1](#T1){ref-type="table"}, entries 10--14). Next, the effect of the solvent on the reaction was tested and replacement of CHCl~3~ with CH~3~CN led to a slightly enhanced yield (83%) ([Table 1](#T1){ref-type="table"}, entries 15 and 16). Additionally, in refluxing CH~3~CN no other Au catalysts afforded better results than Au(JohnPhos)Cl ([Table 1](#T1){ref-type="table"}, entries 17 and 18). Overall, the optimal conditions for the cyclization reaction are as follows: Au(JohnPhos)Cl (10 mol %), CH~3~CN, reflux, 24 h.

###### 

Optimization of the cyclization reaction conditions.^a^

  ------------------------------------------- -------------------------- ----------------------- --------------
  ![](Beilstein_J_Org_Chem-13-817-i001.jpg)                                                      
                                                                                                 
  Entry                                       Catalyst                   Solvent                 Yield^b^ (%)
                                                                                                 
  1                                           AgOTf                      CH~2~Cl~2~              12
  2                                           AgOTf                      CHCl~3~                 45
  3                                           AgOTf                      CH~3~CN                 trace
  4                                           AgOTf                      dioxane                 trace
  5                                           AgSbF~6~                   CHCl~3~                 38
  6                                           Au(PPh~3~)Cl               CHCl~3~                 trace
  7                                           Au(PPh~3~)OTf              CHCl~3~                 42
  8                                           Au(PPh~3~)SbF~6~           CHCl~3~                 21
  9                                           Au(PPh~3~)NTf~2~           CHCl~3~                 70
  10                                          Au~2~(dppe) (SbF~6~)~2~    CHCl~3~                 51
  11                                          Au~2~(binap)( SbF~6~)~2~   CHCl~3~                 53
  12                                          Au(JohnPhos)Cl             CHCl~3~                 78
  13                                          Au(JohnPhos)OTf            CHCl~3~                 42
  14                                          Au(JohnPhos)SbF~6~         CHCl~3~                 74
  **15**                                      **Au(JohnPhos)Cl**         **CH** **~3~** **CN**   **83**
  16                                          Au(JohnPhos)Cl             dioxane                 49
  17                                          Au~2~(dppe) Cl~2~          CH~3~CN                 34
  18                                          Au~2~(binap)Cl~2~          CH~3~CN                 42
  ------------------------------------------- -------------------------- ----------------------- --------------

^a^General conditions: substrate **4a** (0.2 mmol), catalyst (10 mol %), solvent (2 mL) at reflux temperature for 24 h. ^b^Isolated yield.

With the optimal conditions at hand, we then set out to explore the reaction scope for the library generation of structurally diverse imidazo\[1,2-*a*\]pyridine-fused isoquinolines and the results are collected in [Table 2](#T2){ref-type="table"}. Initially, several GBB adducts **4** were synthesized through GBB reaction of amidines **1**, substituted 2-ethynylbenzaldehydes **2** and *tert*-butylisocyanide (**3**). Indeed, the acetylene group in the aldehyde component had no obvious steric effect on the efficiency of the GBB reaction affording the GBB product in good to excellent yields in most cases. On the other hand, the substituent ortho to the amino group in the amidine component had a negative effect on the GBB reaction efficiency due to steric hindrance ([Table 2](#T2){ref-type="table"}, entries 6, 11, 13 and 17).

###### 

Substrate scope for the syntheses of compounds **4** and **6**.^a^

  ------- ------------------------------------------- -------------------------------------------- -------------- -------------------------------------------- --------------
  Entry   Starting materials                          GBB product **4**                            Yield^b^ (%)   Cyclized product **6**                       Yield^b^ (%)

                                                                                                                                                               

  1       ![](Beilstein_J_Org_Chem-13-817-i002.jpg)   ![](Beilstein_J_Org_Chem-13-817-i003.jpg)\   94             ![](Beilstein_J_Org_Chem-13-817-i004.jpg)\   72
                                                      **4b**                                                      **6b**                                       

  2       ![](Beilstein_J_Org_Chem-13-817-i005.jpg)   ![](Beilstein_J_Org_Chem-13-817-i006.jpg)\   80             ![](Beilstein_J_Org_Chem-13-817-i007.jpg)\   75
                                                      **4c**                                                      **6c**                                       

  3       ![](Beilstein_J_Org_Chem-13-817-i008.jpg)   ![](Beilstein_J_Org_Chem-13-817-i009.jpg)\   62             ![](Beilstein_J_Org_Chem-13-817-i010.jpg)\   61
                                                      **4d**                                                      **6d**                                       

  4       ![](Beilstein_J_Org_Chem-13-817-i011.jpg)   ![](Beilstein_J_Org_Chem-13-817-i012.jpg)\   96             ![](Beilstein_J_Org_Chem-13-817-i013.jpg)\   63
                                                      **4e**                                                      **6e**                                       

  5       ![](Beilstein_J_Org_Chem-13-817-i014.jpg)   ![](Beilstein_J_Org_Chem-13-817-i015.jpg)\   89             ![](Beilstein_J_Org_Chem-13-817-i016.jpg)\   78
                                                      **4f**                                                      **6f**                                       

  6       ![](Beilstein_J_Org_Chem-13-817-i017.jpg)   ![](Beilstein_J_Org_Chem-13-817-i018.jpg)\   61             ![](Beilstein_J_Org_Chem-13-817-i019.jpg)\   80
                                                      **4g**                                                      **6g**                                       

  7       ![](Beilstein_J_Org_Chem-13-817-i020.jpg)   ![](Beilstein_J_Org_Chem-13-817-i021.jpg)\   85             ![](Beilstein_J_Org_Chem-13-817-i022.jpg)\   56
                                                      **4h**                                                      **6h**                                       

  8       ![](Beilstein_J_Org_Chem-13-817-i023.jpg)   ![](Beilstein_J_Org_Chem-13-817-i024.jpg)\   88             ![](Beilstein_J_Org_Chem-13-817-i025.jpg)\   58
                                                      **4i**                                                      **6i**                                       

  9       ![](Beilstein_J_Org_Chem-13-817-i026.jpg)   ![](Beilstein_J_Org_Chem-13-817-i027.jpg)\   64             ![](Beilstein_J_Org_Chem-13-817-i028.jpg)\   78
                                                      **4j**                                                      **6j**                                       

  10      ![](Beilstein_J_Org_Chem-13-817-i029.jpg)   ![](Beilstein_J_Org_Chem-13-817-i030.jpg)\   75             ![](Beilstein_J_Org_Chem-13-817-i031.jpg)\   87
                                                      **4k**                                                      **6k**                                       

  11      ![](Beilstein_J_Org_Chem-13-817-i032.jpg)   ![](Beilstein_J_Org_Chem-13-817-i033.jpg)\   49             ![](Beilstein_J_Org_Chem-13-817-i034.jpg)\   79
                                                      **4l**                                                      **6l**                                       

  12      ![](Beilstein_J_Org_Chem-13-817-i035.jpg)   ![](Beilstein_J_Org_Chem-13-817-i036.jpg)\   71             ![](Beilstein_J_Org_Chem-13-817-i037.jpg)\   48
                                                      **4m**                                                      **6m**                                       

  13      ![](Beilstein_J_Org_Chem-13-817-i038.jpg)   ![](Beilstein_J_Org_Chem-13-817-i039.jpg)\   47             ![](Beilstein_J_Org_Chem-13-817-i040.jpg)\   55
                                                      **4n**                                                      **6n**                                       

  14      ![](Beilstein_J_Org_Chem-13-817-i041.jpg)   ![](Beilstein_J_Org_Chem-13-817-i042.jpg)\   54             ![](Beilstein_J_Org_Chem-13-817-i043.jpg)\   62
                                                      **4o**                                                      **6o**                                       

  15      ![](Beilstein_J_Org_Chem-13-817-i044.jpg)   ![](Beilstein_J_Org_Chem-13-817-i045.jpg)\   95             ![](Beilstein_J_Org_Chem-13-817-i046.jpg)\   63
                                                      **4p**                                                      **6p**                                       

  16      ![](Beilstein_J_Org_Chem-13-817-i047.jpg)   ![](Beilstein_J_Org_Chem-13-817-i048.jpg)\   74             ![](Beilstein_J_Org_Chem-13-817-i049.jpg)\   58
                                                      **4q**                                                      **6q**                                       

  17      ![](Beilstein_J_Org_Chem-13-817-i050.jpg)   ![](Beilstein_J_Org_Chem-13-817-i051.jpg)\   43             ![](Beilstein_J_Org_Chem-13-817-i052.jpg)\   67
                                                      **4r**                                                      **6r**                                       

  18      ![](Beilstein_J_Org_Chem-13-817-i053.jpg)   ![](Beilstein_J_Org_Chem-13-817-i054.jpg)\   57             ![](Beilstein_J_Org_Chem-13-817-i055.jpg)\   59
                                                      **4s**                                                      **6s**                                       
  ------- ------------------------------------------- -------------------------------------------- -------------- -------------------------------------------- --------------

^a^GBB reaction conditions: **1** (0.5 mmol), **2** (0.5 mmol), **3** (0.6 mmol), MeOH (1 mL); PTSA (5%), room temperature, **12h**; annulation conditions: substrate **4** (0.2 mmol), Au(JohnPhos)Cl (10 mol %), CH~3~CN (2 mL) at reflux temperature for 24 h. ^b^Isolated yields.

Then, the newly generated GBB adducts **4b**--**s** were exposed to the established cyclization conditions to deliver the corresponding imidazo\[1,2-*a*\]pyridine-fused isoquinolines **6b**--**s** in moderate to good yields, and their structures were unambiguously confirmed by ^1^H NMR, ^13^C NMR, and HRMS analysis. Various functionalities related to the amidine and aldehyde components, including electron-donating methoxy and methyl groups or electron-withdrawing halides, were well tolerated. Generally, the substitution pattern of the amidine moiety had little effect on the Au-catalyzed annulation reaction, whereas neutral or electron-donating groups on the aldehyde moiety gave a higher yield in comparison with the electron-withdrawing halides. Notably, bromo-substituted substrates were also tolerated the reaction conditions, allowing for the further manipulation through various cross-coupling reaction ([Table 2](#T2){ref-type="table"}, entry 9).

Conclusion
==========

In conclusion, we have developed a practical and efficient synthetic approach to structurally diverse imidazo\[1,2-*a*\]pyridine-fused isoquinolines with moderate to good yields through the GBB multicomponent reaction/Au-catalyzed cyclization strategy. The described method provides a new tool for a rapid compound library generation from readily accessible starting materials. Further, the protocol tolerates a broad substrate scope, which will make it attractive for the application in parallel synthesis and combinatorial chemistry.

Experimental
============

**Typical procedure for the GBB multicomponent reaction.** To a solution of 2-aminopyridine (**1a**, 0.5 mmol), 2-ethynylbenzaldehyde (**2a**, 0.5 mmol), and *tert*-butylisocyanide (**3**, 0.6 mmol) in 1 mL of methanol were added *p*-toluenesulfonic acid (4.7 mg, 0.025 mmol) and the reaction mixture was stirred at rt for 12 h. The mixture was diluted with 15 mL of dichloromethane and washed successively with water (10 mL), saturated NaHCO~3~ solution (10 mL) and brine (10 mL). After drying over anhydrous Na~2~SO~4~, the mixture was concentrated under vacuum and the resulting residue was purified by flash chromatography (hexane/ethyl acetate 8:1) to afford GBB adduct **4a** (90% yield).

**Typical procedure for the Au-catalyzed cyclization reaction.** To a solution of the GBB adduct **4** (0.2 mmol) in 2 mL of acetonitrile was added Au(JohnPhos)Cl (0.02 mmol) and the resulting mixture was stirred under inert atmosphere at reflux temperature for 24 h. Then, the solvent was removed under vacuum and the residue purified by flash chromatography (hexane/ethyl acetate 5:1) to afford the desired product **6**.

Supporting Information
======================

###### 

Characterization data for all compounds and copies of NMR spectra for compounds **6a**--**s**.
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